Research Catalog

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.

Title
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Publication
Washington : U.S. Government Publishing Office, 2018.

Details

Description
v, 136 pages : illustrations; 24 cm
Alternative Title
Examining Food and Drug Administration's generic drug and biosimilar user fee programs
Subject
  • United States. Food and Drug Administration > Rules and practice
  • United States. Food and Drug Administration
  • Generic drugs > Prices > United States
  • Prescription pricing > Law and legislation > United States
  • User charges > Law and legislation > United States
  • Drug accessibility > Government policy > United States
  • Drugs > Law and legislation > United States
  • Drugs > Law and legislation
  • Generic drugs > Prices
  • Prescription pricing > Law and legislation
  • User charges > Law and legislation
  • United States
Genre/Form
  • Legislative hearings.
  • Rules.
Note
  • Shipping list no.: 2021-0077-M.
  • "Serial No. 115-10."
Bibliography (note)
  • Includes bibliographical references.
Reproduction (note)
  • Microfiche.
Call Number
GPO Microfiche Y 4.C 73/8:115-10
OCLC
marcive1294314497
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Title
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Publisher
Washington : U.S. Government Publishing Office, 2018.
Type of Content
text
Type of Medium
microform
Type of Carrier
microfiche
Bibliography
Includes bibliographical references.
Reproduction
Microfiche. [Washington, D.C.] : U.S. Government Publishing Office, [2018?] 2 microfiches : negative.
Other Form:
Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining FDA's generic drug and biosimilar user fee programs (DLC) 2018439914 (OCoLC)1078699092
Online version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining FDA's generic drug and biosimilar user fee programs (OCoLC)1259368245
Gpo Item No.
1019-B-01 (MF)
Sudoc No.
Y 4.C 73/8:115-10
View in Legacy Catalog